8/13/2019 53991583 Overview IV Therapy
1/41
Test 1- WALDEN
IV THERAPY:
1. PURPOSE- To access the venous circulation in order to dra !lood "or la!orator# screens
and dia$nostic tests or to ad%inister "luids& electrol#tes& %edications& !lood& !lood
'roducts &and nutritional su''le%ents.
Indicated "or situations hen oral or other 'arenteral routes are not
a''ro'riate.
(ontinuous IV ad%inistration
Inter%ittent IV is used 'ri%aril# "or IV %edication ad%inistration
)olus increase in %edication i%%ediatel#
IV %edications !#'ass the en*#%atic 'rocess o" the liver
+ursin$ Res'onsi!ilities
,noin$ IV sets and their "unctions
(alculatin$ IV dri' rates
iin$ and dilutin$ %edications in IV "luids
,noin$ the %edications& 'ur'oses& and side e""ects
+ursin$ Res'onsi!ilities continued
Assess%ent o" the client& site& in"iltration& rates& adverse reactions& thera'eutic actions
IV route is the "astest onset o" %edication ad%inistration& hoever& once in/ected& the %edication
can not !e retrieved
IV route could 'rovide a direct route "or conta%ination ith 'atho$ens
(losel# %onitor the client "or adverse reactions
IV (onsiderations
Is "luid loss severe or li"e-threatenin$0
hat is %issin$0
hat is current health status0 (o- %or!idities: cardiac& renal& liver& 'ul%onar#& I 2 O
8/13/2019 53991583 Overview IV Therapy
2/41
3ail# ei$ht 4 "luids calculated on chan$es in current ei$ht
5To 6ilo$ra%s o" ei$ht $ain is e7uivalent to 8 liters o" "luid $ain
9 'ounds 8.9 liters "luid
Restorin$ "luids !# IV
h#: "luid; !lood loss& 'recautionar#
8/13/2019 53991583 Overview IV Therapy
3/41
-
8/13/2019 53991583 Overview IV Therapy
4/41
Use o" nettin$ to secure
Avoid restraints 'recaution
ental status assess%ent
EI3
>au$e and luid Rate
8B $au$e @#ello 19-89%l;%in
88 $au$e @!lue 8C-FC %l;%in
8G $au$e @'in6 9G-C9 %l;%in @%aintenance rate
1 $au$e @$reen 9-1G9 %l;%in
@hen lar$e !olus ra'id in"usion needed
>eriatrics
88 4 8B $au$e
Tourni7uet %a# not !e necessar#
Position hand de'endent
+o sla''in$ see !o 19- F 'a$e BBD Techni7ues.
Re%e%!er $eriatric care.
(entral venous catheters
central linesJ
ultilu%en or sin$le lu%en non-tunneled
8/13/2019 53991583 Overview IV Therapy
5/41
aintenance @"lushin$ K shi"t- R+
(entral lines cont.
Uses
$lood sampling
C%& monitoring
Continuous' intermittent drug infusions
iagnostic testing
Simultaneous infusion of seeral medications
%iscous or high-olume fluids ' blood
"& (total parenteral nutrition)
PI(( IV access @alternate access
Peri'herall# inserted central catheters @ar%
8/13/2019 53991583 Overview IV Therapy
6/41
Su!clavian& /u$ular& or "e%oral catheter
Te%'orar# vascular access
To 'orts - !lue and red
Used "or acute he%odial#sis
3 to insert
Sutured to s6in
S'ecial trainin$ to access
Accounta!ilit# and In"usion Thera'#
The R+ is accounta!le "or 6noin$
*hat is ordered
*hy it is intended
+mpact on the patient
Any possible side effects
,o to administer the infusion
,o to maintain the infusion
,o to discontinue properly
,o to document appropriately
R+ Res'onsi!ilities
The R+ re%ains accounta!le and res'onsi!le "or all dele$ated tas6s and %ust have a clear
6noled$e o" the nursin$ sco'e o" 'ractice relative to assess%ent& 'lannin$& i%'le%entation& and
evaluation o" in"usion thera'#& as ell as le$al res'onsi!ilities associated ith dele$ation o"
nursin$ care activities.J @I+S& 8GGG
R+?s Res'onsi!ilities
3ele$ate certain nursin$ tas6s to licensed and unlicensed 'ersonnel
Still res'onsi!le "or tas6s dele$ated
ust evaluate others co%'etenc#& instruct the%& and veri"# 'ro'er trainin$
8/13/2019 53991583 Overview IV Therapy
7/41
Res'onsi!ilities %a# var# a%on$ states and e%'lo#ers
(o%'ati!ilit#
+urse is res'onsi!le to veri"# co%'ati!ilit# o" "luids ith %edication ad%inistered via IV
Or i" a edication is in the IV "luid and a dru$ is $iven inter%ittentl#
+urse %ust %a6e certain "luids and dru$s are co%'ati!le.
IV Thera'#
R+ vs.
8/13/2019 53991583 Overview IV Therapy
8/41
B. (hec6 to see i" the anti!iotic is co%'ati!le ith the soluitions in"usin$.
(O+SI3ER A>E+(Y IV THERAPY PO
8/13/2019 53991583 Overview IV Therapy
9/41
IV Thera'# that is ordered "re7uentl# "or short 'eriods o" ti%e.
EN:
.ocephin 1gm +%&$ / 12 hours doses
emerol 23mg +%& / 4- hours &. pain
IV 'ush @IVP or IV 'i$$#!ac6 @IVP)& secondar#
Re7uires tu!in$ and site chan$e 7 B-D8 hours
re7uent site %onitorin$
luid in"used recorded on chart 7 shi"t
IVP @IV 'ush %edications
(hec6 order
Pre'are %edications and chec6 co%'ati!ilit# ith "luids
Assess site
Select 'ort 'roi%al to 'atient
(lean 'ort ith alcohol sa!
lush ith 1G%l o" +S !e"ore %edication
Insert;attach %edication s#rin$e
Occlude IV tu!in$ a!ove 'ort @'inch
Pull !ac6 $entl# to as'irate !lood return @%a# not $et
In/ect %edication in desi$nated ti%e "ra%e @loo6 u' in dru$ !oo6
Release tu!in$ i" "luids runnin$ - i" saline loc6& "lush ith 1G%l o" +S and loc6
S%all volu%e needs to han$ hi$her
IV PUSH
3ra u' correct dose into a 1G%< s#rin$e.
Veri"# dose ith second nurse
Then add additional saline to s#rin$e to e7ual 1G %
8/13/2019 53991583 Overview IV Therapy
10/41
Pause.
8/13/2019 53991583 Overview IV Therapy
11/41
:ay be anyhere from
8/13/2019 53991583 Overview IV Therapy
12/41
89Q
H#'o'roteine%ia
Volu%e E'ansion
Others are 3etran& s#nthetic colloid %ade o" $lucose-
o!ili*es interstitial ede%a
Hetastarch @Hes'an ade "ro% corn.
o!ili*es interstitial ede%a
Volu%e e'anders
Plas%a 'las%anate @Plas%a 'rotein "raction
(ontains hu%an 'las%a 'roteins in +or%al Saline @+S.
Increases seru% colloid os%otic 'ressure
T#'es o" intravenous solutions
Isotonic
ormal Saline (S) ! .ingers actate(.)
etrose in ater (3*)
H#'otonic
043= ormal Saline
0
8/13/2019 53991583 Overview IV Therapy
13/41
8/13/2019 53991583 Overview IV Therapy
14/41
Push "luid into cells : h# %i$ht e see %ental status chan$e0
h# is 39 isotonic in the !a$
A+3 HYPOTO+I( in the vein
>lucose enters the vascular co%'art%ent
Is then ra'idl# %eta!oli*ed !# the
8/13/2019 53991583 Overview IV Therapy
15/41
8/13/2019 53991583 Overview IV Therapy
16/41
aintain ater !alance
Pro%ote sodiu% diuresis
3etrose in Saline
39+S
391;8 +S
31G +S
Pro%otes diuresis
(orrect %oderate "luid loss
Prevent al6alosis
Provides calories and sodiu% chloride
Electrol#tes
8/13/2019 53991583 Overview IV Therapy
17/41
h# is an EI3 used "or concentrated !olus ad%inistered.
hat is a concentrated !olus.
TP+
+utritional ade7uate h#'ertonic solution consistin$ o" $lucose and other nutrients andelectrol#tes $iven throu$h an indellin$ 'eri'heral or central line
Used as intervention in severe cases o" %alnutrition.
TP+ 000000
h# should e %onitor >lucose ever# C hours0
h# should e not allo the solution container o" TP+ run out0
h# should e closel# %onitor T P R and );P0 )(0 In"usion site0 h# is ase'sis so vital0
TO START A+ IV==
3e%onstration in la!
E7ui'%ent and Su''lies
IV catheter @8B>A& 88>A& 8G>A& 1>A& 1C>A
IV start 6it @dra'e& cleanin$ and antise'tic 're's& dressin$s& ta'e& la!el& tourni7uet& trans'arent
dressin$
>
8/13/2019 53991583 Overview IV Therapy
18/41
luids vs. PR+ loc6 @saline or he'arin
Tu!in$ and etension
edication; )lood ad%inistration
Pu%'s& dial-a-"lo& volu%e control device @$ravit#
(hildren
Aller$# to iodine& late& or ta'e
Ar% !oard
Trans'arent dressin$; ta'e
Practice correctl#
Assess%ent "or initiatin$ IV thera'#
Asse%!le correct su''lies
Revie 3?s order
9 ri$hts
Assess "or clinical "actors; conditions
Assess 'revious e'erience; e'ectations
(onsider "uture treat%ents
Aller$ies; la! data @!etadine ta'e
Plannin$ "or initiatin$ IV thera'# @$oals
2 E )alance and VS ill return to nor%al
IV line ill !e 'atent
Site ill !e !eni$n
(lient ill understand 'ur'ose
IV site selection
A$e and status o" 'atient
Pur'ose o" the in"usion
8/13/2019 53991583 Overview IV Therapy
19/41
3uration o" thera'#
(ondition o" 'atient?s veins
8/13/2019 53991583 Overview IV Therapy
20/41
Use distal vein to 'roi%al
ar% co%'ress
(hec6 arterial 'ulse to ensure ade7uate !lood "lo to "ill veins
hen 're' i'e accordin$ to 'olic#:
(&'& say distal to proimal)
(hloro-'re'
3o not !lot4 this re%oves anti%icro!ial 'ro'erties
SO ho do e 6no ho "ast to re$ulate the "lo rate00
(ount dro's 19 seconds B $tts ; %inute
Re$ulate "lo rate
Ad/ust rate as 'rescri!ed !# health care 'rovider
"oo slo @ ein clots 'occlude line or client goes into circulatory 'C% collapse
"oo fast @ luid olume ecess (%B)
(alculate rates on 'a'er.
(O+T.
. Per"or% veni'uncture at 8G-FG de$ree an$le.
8/13/2019 53991583 Overview IV Therapy
21/41
3ocu%ent 'rocedure
Patient Teachin$
hen to call the nurse
.edness pain blood dressing loose
lo stops blood in tubing
+% pump alarm
A%!ulate ith IV 'ole& %ove%ent
As6 "or assistance hen needed.
3ocu%entation
o" atte%'ts @I" several %a# chart %ulti'le atte%'tsJ
T#'e o" "luid and "lo rate
Insertion site @A o" catheter
hen in"usion !e$un
Re%e%!er i" it is not docu%ented- IT 3I3 +OT HAPPE+
3O(UE+TATIO+ ENAPA IV catheter
8 atte%'ts
< rist
39 M +S at 1GG;hr
)lood dran
19GG 88>A IV to < rist 8 atte%'ts& !lood dran and sent to la!& 39 M +S 1GG %l;hr 'er
'u%'. Site clear& no redness or ede%a. -------------------------------------------------+ +urse R+
5TIP5
An#ti%e #ou do an#thin$ ith a 'atient?s IV @han$ "luids& $ive %edications& ala#s chec6 the IV
site. I" the IV is not "unctional& then #ou are doin$ nothin$ "or the 'atient. OR #ou %a# !e
8/13/2019 53991583 Overview IV Therapy
22/41
8/13/2019 53991583 Overview IV Therapy
23/41
(irculator# overload
Phle!itis @thro%!o'hle!itis
3e"inition: In"la%%ation o" a vein& o"ten acco%'anied !# "or%ation o" a clot
S 2 SN: Indicated !# 'ain& increased s6in te%'& er#the%a alon$ 'ath o" vein @cord alon$ vein
(lots %a# occur
TN: Sto' in"usion and discontinue IV
Bleate etremity arm moist compresses
.estart ne +% if +% therapy is needed
.otate sites / 48-E2,
(auses: 3ru$ irritation& trau%a to vein& in"ection& stasis& i%%o!ili*ation& IV catheter in 'lace too
lon$
In"iltration
3e"inition: 'rocess in hich a "luid 'asses throu$h the tissues
S 2 SN: Indicated !# sellin$ and 'ossi!le 'ittin$ ede%a& 'allor& coolness& 'ain at insertion site&
'ossi!le decrease or a!sent "lo rate
TN: Sto' in"usion and discontinue IV.
.estart +% in ne location if +% therapy indicated
*arm compresses and eleation of etremity
(auses: IV catheter not in vein& in surroundin$ tissue
Etravasatinon
RE>ITI+E around IV SITE
3O not elevate ar%s
3O not a''l# cold or ar% co%'ress
+oti"# health care 'rovider and "ollo instructions.
hat is di""erence in I+I
8/13/2019 53991583 Overview IV Therapy
24/41
3e"inition: collection o" !lood in tissue or s6in due to trau%a& a6a: !ruise
S 2 SN: discoloration& 'ain& locali*ed ede%a to site
Usuall# sel" li%itin$
TN: Initiall# %oderate 'ressure %a# reduce a%ount o" !ruisin$
(auses: trau%a or inco%'lete he%ostasis a"ter sur$er#
)leedin$
(an occur around veni'uncture site and under s6in
(o%%on in clients on he'arin& ASA
A''l# 'ressure dressin$ to site and docu%ent
E
8/13/2019 53991583 Overview IV Therapy
25/41
3e"inition: entr# o" air into venous circulation
(auses: Secondar# to trau%a& IV tu!in$ not 'ri%ed
8/13/2019 53991583 Overview IV Therapy
26/41
ritten order: !lood co%'onent& volu%e& rate o" in"usion
hen a client is to receive !lood& the nurse is lar$el# res'onsi!le "or its sa"e ad%inistration.
A)O and Rh TYPE
A)O- t#'e o" anti$en co%'onents that R)(?s have.
T#'e A A anti$en
T#'e ) ) anti$en
T#'e A) !oth
T#'e O none
Rh- anti$enic su!stance 'resent in R)(?s
I" have Rh
I" do not have Rh-
Autolo$ous trans"usion
(ollect !lood "ro% client 'rior to e'ected sur$ical 'rocedure& rein"use client ith !lood in
sur$er
Salva$e !lood in sur$er# and ad%inister.
Autolo$ous- donate on !lood.
)lood (o%'onents
hole )lood
PR)(
Platelets @Pranuloc#te (oncentrations
Plas%a
(lottin$ actors
8/13/2019 53991583 Overview IV Therapy
27/41
Other volu%e e'anders
hole )lood
Used in esan$uinations@)leedin$ 'atient
(ontains all !lood 'roducts
Usuall# contains BGG %l -
USE3 hen !oth volu%e and cells are needed
hole )lood
R)(& 'las%a& 'las%a 'roteins ith CF %l o" anticoa$ulant.
9GG %l;unit
A)O identical and Rh "actor %ust %atch
Rarel# indicated
Outco%es: 'revention; resolution o" h#'ovole%ic shoc6 and ane%ia
Ris6: volu%e overload
PR)(?s
Red !lood cells ith anticoa$ulant-'reservative @no clottin$ "actors
Unit si*e- 89G to BGG%l;unit
A)O co%'ati!le& Rh "actor %atch
>iven "re7uentl# !lood loss- sur$er#& trau%a
GQ 'las%a has !een re%oved.
Outco%es: resolution o" ane%ia
PR)(s
>iven "or acute and chronic ane%ia &
)lood loss
3esired over hole !lood in cardiovascular 2 renal co%'ro%ised& and elderl# clients !ecause
PR)(s contain less "luid volu%e.
8/13/2019 53991583 Overview IV Therapy
28/41
Platelets @P
8/13/2019 53991583 Overview IV Therapy
29/41
(r#o'reci'itate
Antihe%o'hilliac "actor VIII and "actor NIII
9-1G%l;unit
(ontains no R)( and a s%all volu%e o" 'las%a
A)O co%'ati!ilit# not needed
Outco%es: correction o" "actor VIII& v& NIII and "i!rino$en de"icienc#& cessation o" !leedin$
(r#o'reci'itate
(o%'onents clottin$ "actors
USES: he%o'hilia& "i!rino$en de"icienc#&
3I(.
Plas%a 3erivatives
Al!u%in- al!u%in& $lo!ulin and other 'roteins
Anti!odies destro#ed durin$ 'rocessin$- co%'ati!ilit# not a "actor
Ra'id in"usion %a# cause h#'otension& !ut 89Q al!u%in can cause a si$ni"icantl# increased
!lood 'ressure !ecause o" its a!ilit# to dra "luid into the intravascular s'ace
(annot trans%it he'atitis or HIV in"ection due to the 'asteuri*ation 'rocess used to 're'are
Outco%es: %aintain; ac7uire ade7uate !lood 'ressure and volu%e su''ort
(lottin$ actors
8/13/2019 53991583 Overview IV Therapy
30/41
Outco%e: 'ro%ote circulator# volu%e and tissue 'er"usion !# ra'idl# e'andin$ 'las%a volu%e
+ot a su!stitute "or !lood or its co%'onents
Volu%e e'anders
Re%ain in vascular s'ace and increase os%otic 'ressure
Plas%a e'ander include detran& hetastarch and 'las%a al!u%in
Al!u%in
A
Al!u%in is availa!le in 9 Q and 89 Q
9 Q al!u%in e'ands vascular s'ace %< "or %+E3
O!tain venous access
Validate Vital si$ns
Re7uest !lood release
(on"ir% !lood acce'ta!ilit#
In"use !lood
onitor durin$ the trans"usion
atch "or trans"usion reaction
Vials %ust !e la!eled and a la!el on 't ar% to %atch.
I+ORE3 (O+SE+T
An in"or%ed consent UST !e o!tained and docu%ented 'rior to !lood ad%inistration
E'lanation to the client or "a%il# %e%!er o" %edical indications "or ho%olo$ous @ho%olo$ous
vs. autolo$ous trans"usion and its !ene"its& ris6s& and alternatives
Assess client histor# "or an# 'revious trans"usions and client?s res'onse
8/13/2019 53991583 Overview IV Therapy
31/41
VE+OUS A((ESS
+eed lar$e !ore IV @8G $au$e or lar$er
a# use a 88 >A "or adults ith s%all veins or children- not !est o'tion
(an use a VA3 @central line& !ut a lar$e volu%e o" re"ri$erated !lood in"used ra'idl# into theventricle can cause cardiac d#srh#th%ias
ar%in$ the !lood can reduce the ris6 o" this co%'lication
(aution
Ra'id in"usion ith cold !lood can cause d#srrh#th%ia
I +E(ESSARY TO use s%all $ua$e %a# need to as6 la! to s'lit unit into to !a$s. S%aller
needle can !e used "or 'latelets& al!u%in and clottin$ "actors.
)lood Release
)e"ore $oin$ to !lood !an6& several thin$s %ust !e done: 'ri%e !lood tu!in$ ith +S onl# and
start +S at ,VO& ta6e VS& 're%edicate i" ordered& !andin$J the 'atient
)lood %ust !e 'ic6ed u' "ro% the !lood !an6 !# an R+
The na%e and identi"ication nu%!er o" the reci'ient %ust !e 'rovided and a 'er%anent record
o" this in"o %aintained in !lood !an6
)lood !an6 is re"rid$erator
There is a !oo6 ith lot nu%!ers and 'atient identi"ication data.
Record
FG %inute indo
)lood %ust !e started ithin thirt# %inutes o" o!tainin$ unit "ro% la!
USE )
8/13/2019 53991583 Overview IV Therapy
32/41
Second chec6 is done at !edside !# 8 R+sW co%'are na%e& nu%!er& A)O& Rh co%'at.& !lood
!and
(hec6 date
Ins'ect !a$ "or lea6s& clots& ecessive air
The orst reactions to !lood are usuall# due to %isidenti"ication o" !lood or client
TU)I+>
ust use !lood tu!in$ ith "ilter.
E%'t# to "ull
REA(TIO+S
GQ o" he%ol#tic trans"usion reactions are "ro% i%'ro'er 'atient to 'roduct identi"ication
8/13/2019 53991583 Overview IV Therapy
33/41
+o other %edications to !e $iven in sa%e tu!in$- EVER @
8/13/2019 53991583 Overview IV Therapy
34/41
8/13/2019 53991583 Overview IV Therapy
35/41
hat i" the rate o" in"usion slos ithout si$ns o" in"iltration00
Su$$est "lush line ith sterile nor%al saline.
hat i"0
Si$ns and s#%'to%s o" VE as short o" !reath or crac6les occurs000
Sto' or slo the in"usion
Elevate the HO)
Vital si$ns
+oti"# 3
Antici'ate 3iuretic; or'hine sul"ate
O#$en
Aller$ic Trans"usion Reaction see Techni7ues C.
re7uenc# 1Q
S 2 S: Urticaria& "lushin$& itchin$& @no "ever
$t: antihista%ines& trans"usion %a# continue
Prevention: treat 'ro'h#lacticall# ith antihista%ines 2 aceta%ino'hine
e'ine'hrine& corticosteroids "or severe reaction
e!rile Trans"usion Reaction
re7uenc#: G.9-1Q
S 2 SN: "ever and;or 'ul%onar# s#%'to%s& sudden chills and "ever& HA& "lushin$& aniet#&
%uscle 'ain
$t: I" "ever and;or 'ul%onar# s#%'to%s- 3O +OT resu%e in"usion& treat shoc6& $ive
anti'#retics
Prevention: (onsider leu6oc#te 'roducts hich have !een "iltered& ashed or "ro*en.
Acute He%ol#tic Trans"usion Reaction
re7uenc#: 1:89&GGG
S 2 SN: chills& "ever& )P& "lushin$& tach#cardia& tach#'nea& h#'otension& vascular colla'se&
8/13/2019 53991583 Overview IV Therapy
36/41
8/13/2019 53991583 Overview IV Therapy
37/41
hat i"0000
I" reaction is sus'ected& should nurse turn saline on and allo saline to "lo throu$h tu!in$0
h# han$ saline ith !lood trans"usion and not detrose0
Anser: 3etrose cause coa$ulatio o" donor !lood.
Ana'h#lactic Trans"usion Reaction
re7uenc#: 1:19G&GGG
S 2 SN: aniet#& urticaria& hee*in$& d#s'nea
'ro$ressin$ to c#anosis& shoc6& cardiac arrest
$t: Sto' trans"usion& (PR i" needed& have E'ine'hrine read# "or in/ection
Prevention: >iven !lood "ro% I$A de"icient donors or 'las%a ash
3O +OT restart trans"usion
3ela#ed trans"usion reactions
3ela#ed he%ol#tic
He'atitis ) and (
HIV
Iron Overload
est +ile Virus
a# occur ee6s to %onths a"ter the trans"usion.
)lood (ollection
)lood s'eci%en collection
ost co%%onl# used dia$nostic aids in the care and evaluation o" clients
Yield valua!le in"or%ation a!out nutritional& he%atolo$ical& %eta!olic& i%%une and !ioche%ical
status
Screen "or earl# si$ns o" disease& 'lot current treat%ent course& and %onitor res'onse to thera'#
a# !e 'er"or%ed !# R+& or other trained 'ersonnel
8/13/2019 53991583 Overview IV Therapy
38/41
8/13/2019 53991583 Overview IV Therapy
39/41
)lood tu!es
I3 la!els "or tu!es
A !utter"l#
Sterile s#rin$e
Vaccutainer tu!e
Sterile dou!le ended needle 8G-89>A
Anaero!ic and aero!ic culture !ottles
Su''lies de'end on hat !lood tests are ordered
(onsider- !e"ore #ou stic6
Antici'ate client?s aniet#
Assess "or an# 'ossi!le ris6s
Is the 'atient a!le to coo'erate0
(ontraindicated sites0
So%e s'eci%ens re7uire s'ecial collection re7uire%ents- 6no "acilit# 'olic#
hich tu!e do I use0
Pur'le - !lood cell counts @()(
Solid red - dru$ levels in !lood
S'ec6led red - che%istr#; electrol#te levels
)lue - clottin$ ti%es
>reen - cardiac s'eci"ic
ZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZ
555THIS VARIES RO A(I
8/13/2019 53991583 Overview IV Therapy
40/41
>ather su''lies
ash hands
Provide 'rivac#& 'osition 'atient
A''l# tourni7uet @1 %in %a
A''l# $loves
3eter%ine !est site- strai$ht& 'ro%inent vein
(leanse site and allo to dr#
Pull s6in taut& hold needle at 19-FG de$ree an$le ith !evel u'
Procedure cont.
Slol# insert into vein- "eel the 'o'J
ithdra !lood hile 6ee'in$ needle sta!ili*ed
Release tourni7uet hen !lood collected
A''l# sterile 'ressure dressin$
3is'ose o" su''lies 'ro'erl#
The )lood dra and the IV line
I" ne IV& dra !lood "ro% hu! !e"ore "lushin$
I" it is an old IV line- TOO )A3
hen drain$ !lood "or la!& avoid the ar% ith the IV 4 it %a# alter la! results
I" have to use sa%e ar%& turn o"" "luids "or 1G %inutes and use site distal to IV i" 'ossi!le
Handlin$ )lood S'eci%ens
Rotate !lood tu!es $entl# a"ter dra
8/13/2019 53991583 Overview IV Therapy
41/41
3is'osal o" %aterials
+eedles- shar's
I" not saturated ith !lood %a# $o into re$ular $ar!a$e. I" saturated ith !lood %ust $o into
!ioha*ard rece'tacle.
IV "luid !a$s can $o into the $ar!a$e hen drained& tu!in$ %ust $o in !ioha*ard container
)lood collection de%onstrated in la!
Vaccutainer
)utter"l#
ro% IV site
S%all orld
Positive "luid dis'lace%ent. (